Markt für Brustkrebs-Screening – Erkenntnisse aus globaler und regionaler Analyse – Prognose bis 2031

  • Report Code : TIPRE00009796
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 156
Buy Now

[Forschungsbericht]Der Markt für Brustkrebs-Screening wird bis 2027 voraussichtlich 6.209,25 Mio. US-Dollar erreichen, gegenüber 4.638,63 Mio. US-Dollar im Jahr 2019; Es wird geschätzt, dass sie von 2020 bis 2027 mit einer jährlichen Wachstumsrate von 4,8 % wachsen wird.



Brustkrebs ist die häufigste und am weitesten verbreitete Krebsart bei Frauen; Es entwickelt sich im Brustgewebe, normalerweise in den Milchgängen (Röhren, die die Milch zur Brustwarze transportieren) und Läppchen (Drüsen, die Milch produzieren). Es kann auch im Fettgewebe oder im faserigen Bindegewebe der Brust auftreten. Eine frühzeitige Diagnose von Brustkrebs ist wichtig, da sie verhindern kann, dass die Erkrankung kritisch wird, und eine erfolgreiche heilbare Behandlung sicherstellen kann. Zu den Screening-Methoden zur Diagnose von Brustkrebs gehören Mammographie, Magnetresonanztomographie (MRT), Ultraschall und andere. Das Hauptziel des Screenings besteht darin, Krankheiten im frühesten und behandelbarsten Stadium zu erkennen. Die Screening-Verfahren erkennen die frühen Anzeichen von Krebs, noch bevor sich die Symptome zeigen.



Lukrative regionale Brustkrebs-Screening-Märkte

Markteinblicke



Global wachsende Brust Krebsprävalenz



Brustkrebs gehört weltweit zu den Haupttodesursachen und beeinträchtigt die Lebensqualität erheblich. Daher stellt es eine Belastung für die Gesellschaft dar, wenn es nicht rechtzeitig diagnostiziert und behandelt wird. Nach Schätzungen der American Cancer Society ist Brustkrebs die häufigste Krebsart in den USA, da er 2018 bei etwa 234.087 Menschen Morbidität verursachte und zu 41.904 Todesfällen führte. Darüber hinaus werden im Land etwa 276.480 neue Fälle erwartet 2020. Laut dem Globocan-Bericht 2019 betrug die Gesamtzahl der Brustkrebsfälle in Deutschland im Jahr 2018 71.888, und die Krankheit führte in diesem Jahr zu etwa 19.376 Todesfällen. Darüber hinaus gab es laut dem Globocan-Bericht im Jahr 2018 in China etwa 367.900 neue Fälle von Brustkrebs und 97.972 Todesfälle aufgrund derselben. In Indien legen NGOs, Regierungsbehörden und Wohltätigkeitsorganisationen Wert auf die Sensibilisierung der Bevölkerung für Brustkrebs, um die Früherkennung zu fördern, ein umfassendes Behandlungsmodul bereitzustellen und die Unterstützung für die Behandlung von Brustkrebs auszuweiten. Solche Initiativen sind ein Ergebnis der zunehmenden Prävalenz dieser Krebsart im Land. Laut der Schätzung des Globocan-Berichts meldete Indien im Jahr 2018 etwa 162.468 neue Brustkrebsfälle und 87.090 Todesfälle aufgrund derselben. Die zunehmende Prävalenz von Brustkrebs in verschiedenen Regionen der Welt erhöht die weltweite Nachfrage nach entsprechenden Screening-Geräten.





Testtypbasierte Markteinblicke



Der Markt für Brustkrebs-Screening ist nach Produkttyp in Blutmarkertests, bildgebende Tests, Gentests und immunhistochemische Tests unterteilt. Das Segment der Bildgebungstests hielt 2019 den größten Marktanteil und wird im Prognosezeitraum voraussichtlich auch die höchste CAGR auf dem Markt verzeichnen.



Globaler Markt für Brustkrebs-Screening nach Produkttyp – 2018 und 2027



Endbenutzerbasierte Erkenntnisse



Auf der Grundlage des Endbenutzers wurde der Markt für Brustkrebs-Screening in Krankenhäuser, Diagnosezentren, Krebsinstitute und Forschungslabore segmentiert. Das Krankenhaussegment hielt 2019 den größten Marktanteil, während das Segment der Diagnosezentren im Prognosezeitraum voraussichtlich die höchste CAGR auf dem Markt verzeichnen wird.



Strategische Einblicke



Produkt Markteinführungen und Zulassungen sind eine von Unternehmen im Brustkrebs-Screening-Markt häufig angewandte Strategie, um ihre Präsenz weltweit auszubauen und der wachsenden Nachfrage durch die Erweiterung ihres Produktportfolios gerecht zu werden. Sie verfolgen außerdem eine Expansionsstrategie, um den Kundenstamm auf der ganzen Welt zu vergrößern, was es ihnen auch ermöglicht, ihren Markennamen weltweit aufrechtzuerhalten. Beispielsweise erhielt Siemens Healthineers im Juni 2017 die Zulassung der Food and Drug Administration (FDA) für das Produkt syngo.via VB20, das voraussichtlich für Molecular Imaging (MI) von Siemens Healthineers verwendet werden wird – eine neue Version der etablierten intelligenten Visualisierung des Unternehmens Software für multimodale Bildgebung.



Markt für Brustkrebs-Screening – nach Produkttyp




  • Blutmarkertest

  • Bildgebungstest

  • Gentest

  • Immunhistochemischer Test


Brustkrebs-Screening-Markt – nach Anwendung




  • Diagnosezentren

  • Krankenhäuser

  • Forschungslabore

  • Krebsinstitute


Brustkrebs-Screening – nach Geographie




  • Nordamerika

    • USA

    • Kanada

    • Mexiko



  • Europa

    • Frankreich

    • Deutschland

    • Italien

    • Großbritannien

    • Spanien

    • Restliches Europa



  • Asien-Pazifik

    • China

    • Indien

    • Südkorea

    • Japan

    • Australien

    • Rest Asien-Pazifik



  • Naher Osten und Afrika

    • Südafrika

    • Saudi-Arabien

    • VAE
    • Übriger Naher Osten und Afrika



  • Südamerika

    • Brasilien

    • Argentinien

    • Rest von Südamerika




Unternehmensprofile




  • General Electric Company

  • Siemens Healthineers AG
  • Exact Sciences Corporation

  • Koninklijke Philips NV

  • Hologic, Inc.

  • BD

  • Myriad Genetics, Inc.
  • Oncozyten Corporation

  • Danaher

  • POC Medical Systems


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are breast cancer screening mean?

The diagnosis of breast cancer is done through breast cancer screening methods such as mammography, magnetic resonance imaging (MRI), ultrasound, and others. Screening examinations are tests performed for early diagnosis of the disease. The foremost goal of screening is to detect disease at its earliest and most treatable stage.

What are the driving factors for the breast cancer screening market across the globe?

The growth of the market is attributed to some key driving factors such as increasing number of breast cancer cases, growing geriatric population and rising adoption of technology for screening purpose. However, high cost of screening method and bassinet on global business due to coronavirus pandemic are expected to restraint the growth of the market during the forecast years.

What is the regional analysis in terms of breast cancer screening?

The North American region holds the largest market for the breast cancer screening. The United States held the largest market for breast cancer screening mean market and is expected to grow due to factors such as increasing number of rising in prevalence of breast cancer, growing developments for screening and imaging process by the companies and others.

The List of Companies - Breast Cancer Screening Market

  1. Koninklijke Philips N.V..
  2. HOLOGIC, INC.
  3. BD
  4. MYRIAD GENETICS, INC.
  5. SIEMENS HEALTHCARE GMBH
  6. Exact Sciences Corporation
  7. ONCOCYTE CORPORATION
  8. POC MEDICAL SYSTEMS
  9. Danaher
  10. GENERAL ELECTRIC

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports